Search or
𝛼SK
𝛼SKbullish
Myungin Pharmaceutical IPO Bookbuilding Analysis
341 Views17 Sep 2025 17:37
Myungin Pharm's IPO price has been confirmed at 58,000 won, which is at the high end of the IPO price range. The demand ratio was 488.9 to 1.
What is covered in the Full Insight:
- Introduction to Myungin Pharmaceutical IPO
- IPO Book Building Results
- Institutional Investors' Demand Analysis
- Lock-up Periods and Share Dynamics
- Financial Forecasts and Valuation Analysis
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 7-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Myungin Pharmaceutical IPO Valuation Analysis22 Aug 2025
- Myungin Pharmaceutical IPO Preview21 Aug 2025
x